• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
topic report
Fierce 15 Hero
Biotech

Introducing Fierce Biotech's 2026 Fierce 15

What does it really mean to be a Fierce 15 biotech in 2026? This is the question we had to ask ourselves when finalizing this year’s list.
James Waldron Oct 5, 2026 7:00am
shutterstock25078614631png

There Is No Such Thing as a Typical Biotech

Brought to you by Syneos Health
Genentech

Genentech pays Alector $100M for preclinical Parkinson’s asset

Oct 5, 2026 10:09am
How to Choose a Biologics CDMO 4 Criteria That Matter the Most

4 Criteria for Choosing the Right Biologics CDMO

Brought to you by Rezon Bio
vials vaccine research vaccines factory manufacturing

Vaxcyte’s pneumococcal shot holds its own against Pfizer, Merck

Oct 5, 2026 8:41am
Red rope red carpet

Gate CEO sees expanded $870M Lilly pact as ‘vote of confidence’

Oct 5, 2026 8:00am
More News

Trio of scientists win Nobel Prize for neuron light switch work

Oct 5, 2026 7:15am

Genmab ph. 2 data spur claim ADC ‘clearly superior’ to Elahere

Oct 5, 2026 4:14am

CSL pays $355M to co-develop Alentis’ ph. 2-stage fibrosis drug

Oct 5, 2026 4:14am

Buzzy AI biotech Xaira unveils antibody platform ambitions

Oct 2, 2026 11:00am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings